Stuttgart - Delayed Quote EUR
Iovance Biotherapeutics Inc (2LB.SG)
1.9208
-0.0204
(-1.05%)
At close: June 13 at 9:56:49 PM GMT+2
Loading Chart for 2LB.SG
- Previous Close
1.9412 - Open
1.9340 - Bid 1.9208 x 200000
- Ask 1.9682 x 200000
- Day's Range
1.9208 - 1.9430 - 52 Week Range
1.4394 - 11.5100 - Volume
0 - Avg. Volume
823 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 6, 2025 - Aug 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 2LB.SG
View MorePerformance Overview: 2LB.SG
Trailing total returns as of 6/13/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
2LB.SG
72.64%
S&P 500 (^GSPC)
1.62%
1-Year Return
2LB.SG
75.64%
S&P 500 (^GSPC)
10.00%
3-Year Return
2LB.SG
74.63%
S&P 500 (^GSPC)
59.40%
5-Year Return
2LB.SG
92.56%
S&P 500 (^GSPC)
96.53%
Compare To: 2LB.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2LB.SG
View MoreValuation Measures
As of 6/13/2025
Market Cap
644.89M
Enterprise Value
381.09M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.18
Price/Book (mrq)
0.97
Enterprise Value/Revenue
2.08
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--